His Excellency Dr Saad bin Saud Al Fuhaid, President of the Arabian Gulf University (AGU), has recently signed a Memorandum of Understanding (MoU) with His Excellency, Professor Dr Hisham bin Saad Al Jadheey, CEO of the Saudi Food and Drug Authority (SFDA), with the aim of cooperating in the field of scientific research, exchanging experiences and experts in clinical research and strategic studies, and training medical students, as well as building capacities of academic and administrative staff members in relevant fields.
Dr Al Fuhaid emphasised the importance of deepening cooperation with the Authority to enhance bilateral cooperation and discuss various mechanisms for exchanging experiences between the two sides, pointing out that the signing of the MoU is seen as a step towards strengthening the bonds of cooperation with specialised institutions in the GCC countries.
Moreover, AGU President noted that the University is a model Gulf regional university that addresses strategic issues in the GCC countries in various fields, such as health, human development, environment, science and technology. He stressed that AGU harnesses all its resources, academic capabilities, and advisory and training expertise to serve the strategic goals of the Cooperation Council countries.
He further pointed out that the University is considered an accredited regional and international training centre by the World Health Organiasation (WHO), the United Nations Development Programme (UNDP), and the United Nations Environment Programme (UNEP).
For his part, Prof. Al Jadheey welcomed the agreement and cooperation with AGU, underlining the importance of exchanging experiences, providing training for medical students, and benefiting from the AGU’s expertise in advisory committees. He also mentioned the cooperation in the field of pharmaceutical laboratories and the provision of consultations to the University, adding that this agreement aims to develop an effective partnership and exchange of experiences by holding training workshops with well-established scientific and academic bodies.
Following the signing ceremony, SFDA CEO and the accompanying delegation visited the University’s medical and research centres, such as the Medical Simulation and Skills Centre, the Anatomy and Pathology Learning Resource Centre (APLRC), and the Anatomy Museum. They also visited the Regenerative Medicine Centre and the Princess Al Jawhara Centre for Molecular Medicine and Genetic Sciences. The delegation was briefed on the AGU’s programmes, including the bachelor’s level in medicine and postgraduate programmes such as the master’s and doctoral programmes in innovation and technology management. Other programmes discussed were the master’s of science in next generation computing, master’s of business administration, doctorate in philosophy of molecular medicine, and diplomas and master’s programmes in regenerative medicine, personalised medicine and clinical research.